DrugPatentWatch Database Preview

Details for Patent: 6,465,504

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,465,504

Title:	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
Abstract:	The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I ##STR1## in which R.sub.1 -R.sub.5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals.
Inventor(s):	Lattmann; Rene (Binningen, SE), Acklin; Pierre (Basel, SE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	09/699,765
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,465,504
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 6,465,504

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,465,504

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	1593/96	Jun 25, 1996

International Family Members for US Patent 6,465,504

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1127
African Regional IP Organization (ARIPO)	9801407
Argentina	007479
Austria	226435